Skip to Content

BioStem Technologies Inc BSEM

Morningstar Rating
$9.15 −0.09 (0.97%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BSEM is trading at a 18% discount.
Price
$9.25
Fair Value
$17.33
Uncertainty
Extreme
1-Star Price
$54.79
5-Star Price
$4.00
Economic Moat
Cxw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BSEM is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$9.24
Day Range
$9.049.25
52-Week Range
$1.2010.60
Bid/Ask
$9.10 / $9.60
Market Cap
$119.87 Mil
Volume/Avg
9,368 / 27,465

Key Statistics

Price/Earnings (Normalized)
Price/Sales
20.19
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
2

Valuation

Metric
BSEM
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
20.19
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BSEM
Quick Ratio
0.38
Current Ratio
0.48
Interest Coverage
−16.99
Quick Ratio
BSEM

Profitability

Metric
BSEM
Return on Assets (Normalized)
−52.95%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−122.00%
Return on Assets
BSEM
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRCgkk$544.0 Bil
VRTX
Vertex Pharmaceuticals IncSjkqn$108.7 Bil
REGN
Regeneron Pharmaceuticals IncHsdbvd$104.0 Bil
MRNA
Moderna IncGkpr$33.2 Bil
ARGX
argenx SE ADRDxn$23.6 Bil
BNTX
BioNTech SE ADRKrvpt$21.7 Bil
ALNY
Alnylam Pharmaceuticals IncNbfgvxb$18.9 Bil
BMRN
Biomarin Pharmaceutical IncFzxcxf$16.7 Bil
RPRX
Royalty Pharma PLC Class AKwyjppz$13.5 Bil
INCY
Incyte CorpQkkxb$13.2 Bil

Sponsor Center